Here is the latest stock price and chart of Sun Pharma. For more details, see the Sun Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since large caps interest you, here's our guide to buying bluechip stocks.
Free Signup: The Smallcap Fortunes Summit
Live BSE Quotes | Mar 2, 2021 (Close) | ||
---|---|---|---|
Price (Rs)614.40 | Open (Rs) 609.25 | High (Rs) 616.30 | Low (Rs) 604.45 |
% Change1.67 | Volume 152,916 | Value (Rs) 93,356,886 | 52-Week H/L 653.70 / 315.20 |
Live NSE Quotes | Mar 2, 2021 (Close) | ||
---|---|---|---|
Price (Rs)614.20 | Open (Rs) 609.00 | High (Rs) 616.35 | Low (Rs) 604.50 |
% Change1.61 | Volume 4,776,776 | Value (Rs) 2,916,418,360 | 52-Week H/L 654.40 / 312.00 |
Change | |||||
---|---|---|---|---|---|
1 Day 1.67% | 1 Month 0.82% | 3 Months 12.73% | 1 Year 66.57% | 5 Years (CAGR)* -6.34% | 10 Years (CAGR)* 11.07% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 8.02 | P/E Ratio (x) 76.58 | Market Cap (Rs m) 1,478,709.04 | P/BV (x) 3.27 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
SUN PHARMA last traded price was up 1.7% to Rs 614.4 on the BSE. On the NSE, SUN PHARMA last traded price was up 1.6% to Rs 614.2. The total volume of shares traded was 4.9 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 1.1%. And the benchmark S&P BSE SENSEX was at 50,296.9 (up 0.9%).
Over the last 30 days, the SUN PHARMA share price is up 4.1%. And over the last one year, SUN PHARMA share price is up 66.6%.
What else is happening in the markets today? Dig in...
Indian share markets witnessed buying interest during closing hours yesterday and ended higher.
For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.
Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.
For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.
Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.
More Views on NewsLast time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
In this video, I'll show you how to get started on the path to daily trading profits.
In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.
An Indian company founded three decades ago in a garage caught my attention...
More